Matthew Jenkin

Matthew Jenkin is an experienced finance professional specializing in healthcare equity investments. Currently serving as Portfolio Manager and Senior Healthcare Research Analyst at Newton Investment Management Group since February 2015, Matthew has previously held significant roles in reputable firms such as BlueCrest Capital Management, LLP, Balyasny Asset Management L.P., and Lehman/Barclays Capital Equity Strategies, focusing on healthcare alternative investments. Matthew began their career at Dreyfus as a healthcare portfolio manager and analyst, managing sizable healthcare investments. Academic achievements include a Bachelor of Science degree in Physiology and Molecular Biology from Tulane University and an MBA in Finance and Economics from New York University - Leonard N. Stern School of Business.